The rating includes leading Russian pharmaceutical companies. Companies were evaluated according to five criteria: annual revenue, revenue change for a year, net profit, number of marketing authorizations and number of clinical trial approvals.
The rating includes leading Russian pharmaceutical companies. Companies were evaluated according to five criteria: annual revenue, revenue change for a year, net profit, number of marketing authorizations and number of clinical trial approvals.